BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

403 related articles for article (PubMed ID: 24458079)

  • 1. Prevalence, awareness, and management of CKD and cardiovascular risk factors in publicly funded health care.
    Verhave JC; Troyanov S; Mongeau F; Fradette L; Bouchard J; Awadalla P; Madore F
    Clin J Am Soc Nephrol; 2014 Apr; 9(4):713-9. PubMed ID: 24458079
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Awareness, treatment, and control of major cardiovascular risk factors in a small-scale Italian community: results of a screening campaign.
    Omboni S; Carabelli G; Ghirardi E; Carugo S
    Vasc Health Risk Manag; 2013; 9():177-85. PubMed ID: 23662063
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic kidney disease and cardiovascular risk in six regions of the world (ISN-KDDC): a cross-sectional study.
    Ene-Iordache B; Perico N; Bikbov B; Carminati S; Remuzzi A; Perna A; Islam N; Bravo RF; Aleckovic-Halilovic M; Zou H; Zhang L; Gouda Z; Tchokhonelidze I; Abraham G; Mahdavi-Mazdeh M; Gallieni M; Codreanu I; Togtokh A; Sharma SK; Koirala P; Uprety S; Ulasi I; Remuzzi G
    Lancet Glob Health; 2016 May; 4(5):e307-19. PubMed ID: 27102194
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence, awareness, treatment and control of hypertension, diabetes and hypercholesterolaemia among adults in Dande municipality, Angola.
    Pedro JM; Brito M; Barros H
    Cardiovasc J Afr; 2018 Mar/Apr 23; 29(2):73-81. PubMed ID: 29293258
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patient awareness and beliefs about the risk factors and comorbidities associated with chronic kidney disease : A mixed-methods study.
    Lopez-Vargas PA; Tong A; Howell M; Phoon RK; Chadban SJ; Shen Y; Craig JC
    Nephrology (Carlton); 2017 May; 22(5):374-381. PubMed ID: 27248507
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiovascular risk prevalence, awareness, treatment, and control from 1998 to 2007 in Koreans.
    Lee K
    Asia Pac J Clin Nutr; 2010; 19(2):261-5. PubMed ID: 20460242
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence, determinants, and management of chronic kidney disease in Karachi, Pakistan - a community based cross-sectional study.
    Jessani S; Bux R; Jafar TH
    BMC Nephrol; 2014 Jun; 15():90. PubMed ID: 24927636
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiovascular risk factors awareness and prevalence among primary care physicians: an insight from the West region Awareness Initiative Survey to fight cardiovascular disease (WAIT-CVD) in Cameroon.
    Jingi AM; Noubiap JJ
    BMC Res Notes; 2015 Dec; 8():762. PubMed ID: 26652917
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The MAURO study: baseline characteristics and compliance with guidelines targets.
    Leonardis D; Mallamaci F; Enia G; Postorino M; Tripepi G; Zoccali C;
    J Nephrol; 2012; 25(6):1081-90. PubMed ID: 23172127
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quality of cardiovascular disease care in Ontario, Canada: missed opportunities for prevention - a cross sectional study.
    Liddy C; Singh J; Hogg W; Dahrouge S; Deri-Armstrong C; Russell G; Taljaard M; Akbari A; Wells G
    BMC Cardiovasc Disord; 2012 Sep; 12():74. PubMed ID: 22970753
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Awareness of major cardiovascular risk factors and its relationship with markers of vascular aging: Data from the Brisighella Heart Study.
    Cicero AFG; Fogacci F; Tocci G; Ventura F; Presta V; Grandi E; Rizzoli E; D'Addato S; Borghi C;
    Nutr Metab Cardiovasc Dis; 2020 Jun; 30(6):907-914. PubMed ID: 32249143
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Opportunistic screening of cardiovascular disease risk factors in community pharmacies in Nigeria: a cross-sectional study.
    Amadi C; Lawal F; Ajiboye W; Agbim R; Mbakwem A; Ajuluchukwu J; Oke DA
    Int J Clin Pharm; 2020 Dec; 42(6):1469-1479. PubMed ID: 32960427
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of cardiovascular disease burden and therapeutic goal attainment in US adults with chronic kidney disease: an analysis of national health and nutritional examination survey data, 2001-2010.
    Kuznik A; Mardekian J; Tarasenko L
    BMC Nephrol; 2013 Jun; 14():132. PubMed ID: 23802885
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronic kidney disease in Polish elderly population aged 75+: results of the WOBASZ Senior Survey.
    Zdrojewski Ł; Król E; Rutkowski B; Piotrowski W; Pająk A; Drygas W; Zdrojewski T
    Int Urol Nephrol; 2017 Apr; 49(4):669-676. PubMed ID: 27988911
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sex differences in hypertension-related renal and cardiovascular diseases in Italy: the I-DEMAND study.
    Muiesan ML; Ambrosioni E; Costa FV; Leonetti G; Pessina AC; Salvetti M; Trimarco B; Volpe M; Pontremoli R; Deferrari G; Rosei EA
    J Hypertens; 2012 Dec; 30(12):2378-86. PubMed ID: 23137952
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Variation in Patients' Awareness of CKD according to How They Are Asked.
    Tuot DS; Zhu Y; Velasquez A; Espinoza J; Mendez CD; Banerjee T; Hsu CY; Powe NR
    Clin J Am Soc Nephrol; 2016 Sep; 11(9):1566-1573. PubMed ID: 27340288
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The 2010 Canadian Hypertension Education Program recommendations for the management of hypertension: part 2 - therapy.
    Hackam DG; Khan NA; Hemmelgarn BR; Rabkin SW; Touyz RM; Campbell NR; Padwal R; Campbell TS; Lindsay MP; Hill MD; Quinn RR; Mahon JL; Herman RJ; Schiffrin EL; Ruzicka M; Larochelle P; Feldman RD; Lebel M; Poirier L; Arnold JM; Moe GW; Howlett JG; Trudeau L; Bacon SL; Petrella RJ; Milot A; Stone JA; Drouin D; Boulanger JM; Sharma M; Hamet P; Fodor G; Dresser GK; Carruthers SG; Pylypchuk G; Burgess ED; Burns KD; Vallée M; Prasad GV; Gilbert RE; Leiter LA; Jones C; Ogilvie RI; Woo V; McFarlane PA; Hegele RA; Tobe SW;
    Can J Cardiol; 2010 May; 26(5):249-58. PubMed ID: 20485689
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of Prevalence, Awareness, Treatment, and Control of Cardiovascular Risk Factors in China and the United States.
    Lu Y; Wang P; Zhou T; Lu J; Spatz ES; Nasir K; Jiang L; Krumholz HM
    J Am Heart Assoc; 2018 Jan; 7(3):. PubMed ID: 29374046
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Age- and gender-specific awareness, treatment, and control of cardiovascular risk factors and subclinical vascular lesions in a founder population: the SardiNIA Study.
    Scuteri A; Najjar SS; Orru' M; Albai G; Strait J; Tarasov KV; Piras MG; Cao A; Schlessinger D; Uda M; Lakatta EG
    Nutr Metab Cardiovasc Dis; 2009 Oct; 19(8):532-41. PubMed ID: 19321325
    [TBL] [Abstract][Full Text] [Related]  

  • 20. State-Level Awareness of Chronic Kidney Disease in the U.S.
    Dharmarajan SH; Bragg-Gresham JL; Morgenstern H; Gillespie BW; Li Y; Powe NR; Tuot DS; Banerjee T; Burrows NR; Rolka DB; Saydah SH; Saran R;
    Am J Prev Med; 2017 Sep; 53(3):300-307. PubMed ID: 28410862
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.